跳至主要内容
临床试验/NL-OMON51055
NL-OMON51055撤回3 期

Assessment of Treatment with Laparoscopic fenestration or Aspiration Sclerotherapy for large symptomatic hepatic cysts (ATLAS): a randomized clinical trial. - ATLAS-trial

niversitair Medisch Centrum0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
撤回
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age >=18 years
  • Hepatic cyst characteristics:
  • o Large (>5 cm),
  • o Symptomatic (PLD-Q score >=20),
  • o Non-parasitic on imaging (US/CT/MRI)
  • o Non-neoplastic on imaging (US/CT/MRI)
  • Providing informed consent

排除标准

  • Clinical suspicion of a complicated hepatic cyst (cyst rupture or active cyst
  • Cyst is not laparoscopically accessible for surgery
  • Cyst is not percutaneously (ultrasound-guided) accessible for aspiration
  • More than 20 cysts of >1.5 cm
  • Age above 70 years
  • ECOG score >1
  • Aspiration sclerotherapy or laparoscopic fenestration of hepatic cysts was
  • performed in the last 6 months.
  • Severe renal impairment (eGFR < 30 ml/min/1,73 m2)
  • Coagulopathy (spontaneous INR >2 or platelet count < 80 x 10^9/l)
  • Radiologic contrast allergy
  • Pregnancy
  • Any current or prior medical condition that may interfere with the conduct of
  • the study or the evaluation of its results in the opinion of the investigator
  • (e.g. inability to fill out questionnaires).

研究者

发起方
niversitair Medisch Centrum

相似试验